Topic

Symdeko / Symkevi (tezacaftor/ivacaftor)

A collection of 24 issues

Getting Symdeko/Symkevi (Tezacaftor/Ivacaftor) Covered by Cigna in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Your Fastest Path to Coverage To get Symdeko/Symkevi covered by Cigna in Virginia: Submit prior authorization through your CF specialist with complete genotype documentation (including F508del mutation proof), recent pulmonary function tests, and treatment history. Most approvals come within 5 business days when documentation is complete. If
6 min read

How to Get Symdeko/Symkevi Covered by Blue Cross Blue Shield North Carolina: Complete Prior Authorization and Appeals Guide

Quick Answer: Blue Cross Blue Shield of North Carolina covers Symdeko/Symkevi (tezacaftor/ivacaftor) as a Tier 5 specialty medication requiring prior authorization and genetic testing documentation. Submit PA through your CF specialist with CFTR genotype results showing F508del or responsive mutations. If denied, appeal internally within 180 days, then
5 min read

How Long Does It Take to Get Symdeko/Symkevi Approved by UnitedHealthcare in Michigan? Complete Timeline Guide

Quick Answer: Symdeko/Symkevi Approval Timeline with UnitedHealthcare in Michigan UnitedHealthcare typically takes 5-14 business days to approve Symdeko (tezacaftor/ivacaftor) for eligible cystic fibrosis patients in Michigan, provided complete documentation is submitted. Expedited reviews are available within 24-72 hours for urgent cases. The fastest path: have your CF specialist
6 min read

Renewing Symdeko/Symkevi Coverage with Blue Cross Blue Shield Michigan: Complete Guide to Prior Authorization Renewals and Appeals

Answer Box: Renewing Symdeko/Symkevi with BCBS Michigan Blue Cross Blue Shield of Michigan requires annual prior authorization renewal for Symdeko/Symkevi with updated clinical documentation. Submit renewal 30-60 days before expiration with: recent pulmonary function tests, liver function labs (every 3 months year 1, then annually), CF specialist notes
6 min read

Getting Symdeko/Symkevi (Tezacaftor/Ivacaftor) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Coverage Symdeko/Symkevi (tezacaftor/ivacaftor) requires prior authorization from Cigna in Pennsylvania. Submit genetic testing showing F508del mutation, CF diagnosis, and specialist prescription via Cigna's provider portal. If denied, use internal appeals within 180 days, then Pennsylvania's Independent External Review (50%
6 min read

How to Get Symdeko/Symkevi (Tezacaftor/Ivacaftor) Covered by Humana in Illinois: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Symdeko/Symkevi Covered by Humana in Illinois Humana typically requires prior authorization for Symdeko/Symkevi (tezacaftor/ivacaftor) and often classifies it as non-formulary, requiring a formulary exception. To get coverage in Illinois: (1) Submit a complete prior authorization with CF diagnosis, CFTR genotype showing F508del mutation, age
5 min read

How Long Does It Take to Get Symdeko (Tezacaftor/Ivacaftor) Approved by Aetna CVS Health in North Carolina? Complete Timeline Guide

Answer Box: Getting Symdeko Approved by Aetna CVS Health in North Carolina Typical timeline: 1-14 days for standard prior authorization, 24-72 hours for urgent requests. Aetna CVS Health requires prior authorization for Symdeko (tezacaftor/ivacaftor) with documented CF diagnosis, eligible CFTR genotype, and age ≥6 years. Fastest path: Submit complete
5 min read